Abstract
We screened DNAs from 48 Japanese individuals for single-nucleotide polymorphisms (SNPs) in eight cytochrome P450 (CYP) genes, nine esterase genes, and two other genes by directly sequencing the relevant genomic regions in their entirety except for repetitive elements. This approach identified 607 SNPs and 73 insertion/deletion polymorphisms among the 19 genes examined. Of the 607 SNPs, 284 were identified in CYP genes, 302 in esterase genes, and 21 in the other two genes (GGT1, and TGM1); overall, 37 SNPs were located in 5' flanking regions, 496 in introns, 55 in exons, and 19 in 3' flanking regions. These variants should contribute to studies designed to investigate possible correlations between genotypes and phenotypes of disease susceptibility or responsiveness to drug therapy.
Similar content being viewed by others
Introduction
Cytochrome P450 (CYP) enzymes, many of which can catalyze xenobiotic compounds, constitute a superfamily of hemoproteins (Ding and Kaminsky 2003). CYP genes are classified into families and subfamilies on the basis of sequence similarities, and among them, numerous polymorphisms have been previously reported [Human Cytochrome P450 (CYP) Allele Nomenclature Committee, http://www.imm.ki.se/CYPalleles/]. The products of these and the other eleven genes selected for the work reported here are described in the following paragraphs.
CYP2A6 is a major player in the oxidation of nicotine and coumarin in human liver microsomes (Nakajima et al. 1996a; 1996b). Polymorphisms of CYP2A6 that might affect enzymatic activity (Ariyoshi et al. 2001; Kitagawa et al. 2001; Pitarque et al. 2001; Daigo et al. 2002; Oscarson et al. 2002; Xu et al. 2002) or susceptibility to lung cancer (Pianezza et al. 1998; London et al. 1999; Miyamoto et al. 1999) have been reported. However, some of those variants may be rare substitutions or limited to specific ethnic groups (Kitagawa et al. 2001; Oscarson et al. 1999, 2002; Xu et al. 2002).
CYP2A13 may play important roles in xenobiotic toxicity and tobacco-related tumorigenesis in the respiratory tract (Su et al. 2000). Zhang et al. (2002) have identified a C-to-T polymorphism (Arg257Cys) in exon 5 of the gene, and the product of this variant is 37% to 56% less active than the wild-type protein toward all substrates tested.
CYP2B6 is involved in the metabolism of several clinically important drugs (Ekins and Wrighton 1999). Lang et al. (2001) have identified five polymorphisms that would affect amino acid sequences; among them, a C-to-T polymorphism (Arg487Cys) in exon 9 of the gene appears to be associated with enzymatic activity. However, some of those five variants could also be rare substitutions or limited to specific ethnic groups (Hiratsuka et al. 2002).
CYP2E catalyzes the conversion of ethanol to acetaldehyde and to acetate and also metabolizes the pre-mutagenic nitrosamines present in cigarette smoke (Guengerich et al. 1991). Polymorphisms have been associated with increased risk of alcohol-related liver disease (Tanaka et al. 1997; Sun et al. 1999), lung cancer (el-Zein et al. 1997; Oyama et al. 1997; Wu et al. 1997), nasopharyngeal carcinoma (Hildesheim et al. 1997), and oral cancer (Hung et al. 1997).
By screening a database of expressed-sequence tags, Rylander et al. (2001) have identified CYP2S1, a P450 enzyme that is expressed mainly in trachea, lung, stomach, small intestine, and spleen. Rivera et al. (2002) have reported that CYP2S1 is inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) in a cell line derived from human lung epithelium.
Thromboxane A synthase (TBXAS1, CYP5A1) catalyzes the conversion of prostaglandin endoperoxide into thromboxane A2 (Shen and Tai 1986; Jones and Fitzpatrick 1991). TBXAS1 plays an important role in hemostasis and in cardiovascular diseases (FitzGerald et al. 1990). Although eleven polymorphisms have been identified in the promoter region, coding sequences, or 3'-untranslated region (3'UTR) of the TBXAS1 gene, the biological effects of these variants are currently unknown (Chevalier et al. 2001).
CYP7A1 encodes cholesterol 7-alpha-hydroxylase, the rate-limiting enzyme for the conversion of cholesterol to bile acids in the liver (Jelinek et al. 1990). The promoter region of this gene contains a potential DNA-binding site for the transcription factor CPF; mutation of the CPF-binding site abolishes hepatic-specific expression in transient transfection assays (Nitta et al. 1999). Wang et al. (1998) have identified two linked polymorphisms in the 5'flanking region of CYP7A1; the allele defined by these polymorphisms is associated with increased concentrations of low-density lipoprotein cholesterol in plasma.
CYP7B1 encodes oxysterol 7-alpha-hydroxylase (Setchell et al. 1998). This enzyme not only participates the synthesis of primary bile acids from cholesterol but also may be involved in neurosteroid metabolism, synthesis of sex hormones, and detoxification of oxysterols (Setchell et al. 1998; Wu et al. 1999). Mutation in the CYP7B1 gene causes severe neonatal liver disease, an inborn error of bile acid synthesis (Setchell et al. 1998).
Arylacetamide deacetylase (AADAC) is an esterase involved in the metabolic activation of arylamine substrates that ultimately become carcinogenic (Probst et al. 1991). The AADAC gene is expressed in liver, adrenal cortex, adrenal medulla, and pancreas (Trickett et al. 2001).
Carboxyl-ester lipase (CEL), also called cholesterol esterase, plays an important role in the hydrolysis and absorption of cholesterol and lipid-soluble vitamin esters (Lombardo et al. 1980). The 3' portion of the CEL gene is characterized by a GC-rich region (Nilsson et al. 1990), and by a variable number of tandem-repeats sequence (Higuchi et al. 2002).
Carboxylesterases (CESs) constitute a group of serine-dependent esterases (Munger et al. 1991). These enzymes catalyze the hydrolysis of many different endogenous and xenobiotic compounds and play roles in the metabolism of numerous drugs that contain ester and amide bonds (Satoh and Hosokawa 1998). CES1 and CES2, two human-liver carboxylesterases selected for this study, differ in their substrate specificity (Dean et al. 1991; Brzezinski et al. 1994).
Esterase D (ESD), a member of a group of nonspecific esterases, is especially abundant in liver and kidney (Lee et al. 1986). The gene encoding human ESD is a useful genetic marker for retinoblastoma (Lee and Lee 1986).
Granzymes are cytotoxic T-lymphocyte-associated serine esterases (Masson and Tschopp 1987). Granzymes A (GZMA) and B (GZMB) are the most abundantly expressed of the granzymes (Henkart 1994). Both are involved in apoptotic processes, but each uses a distinct pathway (Beresford et al. 1999; Shresta et al. 1999). The GZMA pathway slowly induces apoptosis of target cells, whereas GZMB appears to facilitate the induction of apoptosis (Shi et al. 1992a, 1992b).
Interleukin 17 (IL17), also known as cytotoxic T-lymphocyte-associated serine esterase, is secreted by activated memory CD4+ T cells and modulates the early stage of the immune response (Rouvier et al. 1993; Broxmeyer 1996). High levels of IL-17 may be associated with several chronic inflammatory diseases (Kotake et al. 1999; Molet et al. 2001; Laan et al. 2002).
Ubiquitin carboxyl-terminal esterase L3 (UCHL3) catalyzes C-terminal esters and amides of ubiquitin (Wilkinson et al. 1989). This enzyme is thought to be involved in ubiquitin recycling to maintain the pools of monomeric ubiquitin necessary for proteolysis (Larsen et al. 1998). Johnston et al. (1997) have determined the crystal structure of human UCHL3 and identified active sites.
GGT1 encodes gamma-glutamyltransferase, an enzyme involved in glutathione metabolism (Curthoys and Hughey 1979). Inborn deficiency of GGT1 causes glutathionuria (Schulman et al. 1975; Wright et al. 1980).
TGM1, also known as transglutaminase, is expressed during terminal differentiation of keratinocytes (Candi et al. 1995); this enzyme synthesizes the cornified envelope by a cross-linking reaction (Melino et al. 2000). Mutations in the TGM1 gene cause a skin disease, lamellar ichthyosis (Huber et al. 1995; Russell et al. 1995).
To investigate in detail the nature of apparent genotype/phenotype correlations among the 19 human genes described above, we began by searching for additional SNPs in their promoter regions, exons, and introns (except for repetitive elements) and report here a total of 680 genetic variations, of which 405 had not previously been reported.
Subjects and methods
After informed consent was obtained from each participant, total genomic DNAs were isolated from peripheral leukocytes of 48 unrelated Japanese individuals by the standard phenol/chloroform extraction method. On the basis of sequence information in the GenBank, we designed polymerase chain reaction (PCR) primers to amplify DNA from all 19 genes in their entirety, except that repetitive elements were excluded by invoking the REPEAT MASKER computer program (http://ftp.genome.washington.edu/cgi-bin/RepeatMasker). PCR experiments and DNA sequencing were performed according to methods described previously (Iida et al. 2001; Saito et al. 2001; Sekine et al. 2001). All SNPs detected by the PolyPhred Computer Program (Nickerson et al. 1997) were confirmed by sequencing both strands of each PCR product.
Results
We defined exon-intron boundaries within each of the 19 genes examined by comparing genomic sequences with cDNA sequences. The accession numbers of the genomic sequences and the cDNA sequences used for this study are listed in Table 1. We screened 96 Japanese chromosomes for SNPs in eight CYP genes, and nine esterase genes, plus GGT1 and TGM1, by direct DNA sequencing. The re-sequencing of a total of about 342 kb genomic DNA (153.7 kb for the CYP genes, 171.6 kb for esterases, 16.3 kb for the other two genes) identified 607 SNPs (284 in CYPs, 302 in esterases, and 21 in the other two genes) and 73 insertion/deletion polymorphisms (35 in CYPs and 38 in esterases; Table 2). Among the 680 genetic variations identified in our screening, including insertion/deletion polymorphisms, 405 (60%) had not been reported previously.
CYP genes
Figure 1 illustrates the location of each variation among the CYP genes. Detailed information about nucleotide positions and substitutions is summarized in Table 3; the numbers of SNPs are summarized in Table 4. Among the 284 SNPs found in CYP genes, 13 were located in 5' flanking regions, 231 in introns, 33 in exons, and seven in 3' flanking regions. Among the SNPs detected in exons, 23 were located in coding regions and ten were in 3'UTRs. Among the former, 15 would cause substitution of an amino acid, and seven of those were novel. Of the eight SNPs that were synonymous, three were novel (Table 5).
Esterase genes
Figure 2 illustrates the location of each variation found among the esterase genes examined; detailed information regarding nucleotide positions and substitutions is summarized in Table 6. Among the 302 SNPs, 21 were located in 5' flanking regions, 252 in introns, 17 in exons, and 12 in 3' flanking regions. Of the 17 SNPs detected in exons, one was located in a 5'UTR; ten were in coding regions, and six were in 3'UTRs. Among the SNPs detected in coding regions, five would substitute an amino acid, and two of those were novel. Among the five synonymous SNPs, three were novel (Table 5).
Other genes
Figure 3 illustrates the location of each variation found in the GGT1 and TGM1 genes; detailed information regarding nucleotide positions and substitutions is summarized in Table 7. Among the 21 SNPs, three were located in 5' flanking regions, 13 in introns, and five in exons; three of these five were located in coding regions and the other two in 3'UTRs. Of the three SNPs detected in coding regions, one would cause the substitution of an amino acid, and other two were synonymous SNPs. All three were novel (Table 5).
Discussion
We identified a total of 680 genetic variations (607 SNPs and 73 insertion/deletion polymorphisms) among 19 enzyme-encoding genes selected for this study, by screening DNA from 48 unrelated Japanese individuals with respect to the entire relevant genomic regions except for repetitive sequences. The genes examined included eight cytochrome P450 (CYP) genes and nine esterase genes, plus two others. All data for the genetic variations reported here are available on our website (http://snp.ims.u-tokyo.ac.jp/).
CYP enzymes play central roles in the oxidative metabolism of numerous endogenous substrates, such as steroid hormones, and of xenobiotics, including various carcinogens and toxins (Ding and Kaminsky 2002). Among the CYP genes examined here, other investigators have previously detected 27 polymorphisms that would affect amino acid sequences [ten in CYP2A6, six in CYP2B6, three in CYP2E, and eight in TBXAS1; Human Cytochrome P450 (CYP) Allele Nomenclature Committee, http://www.imm.ki.se/CYPalleles/]. Zhang et al. (2002) have detected an additional SNP (Arg257Cys) in the coding region of CYP2A13. However, of the 28 polymorphisms reported previously, we have found only six in our Japanese population sample (Ile471Thr in CYP2A6; Arg257Cys in CYP2A13; Arg22Cys, Gln172His, and Arg487Cys in CYP2B6; Glu450Lys in TBXAS1). On the other hand, we have found seven novel non-synonymous substitutions (one in CYP2A6, two in CYP2A13, two in TBXAS1, and two in CYP7A1; Table 5). Our results should contribute to a better understanding of ethnic differences in drug responses or possible correlations between genotypes and phenotypes of disease susceptibility.
The promoter region of the CYP7A1 gene contains a potential binding site for a hepatic-specific transcription factor, CPF (CYP7A1 promoter binding factor; Nitta et al. 1999). Although mutation of the CPF site abolishes hepatic-specific expression of the gene in transient transfection assays (Nitta et al. 1999), we have failed to find any variant, including insertion/deletion polymorphisms, in the CPF-binding region among the 96 Japanese chromosomes examined.
Although we have found 302 genetic variations among nine esterase genes, only three represent novel changes that would cause substitutions of amino acids (Table 5). In the AADAC, CES1, CES2, and UCHL3 genes, other research groups have determined presumed active-site residues (Johnston et al. 1997; Pindel et al. 1997; Humerickhouse et al. 2000; Trickett et al. 2001); however, we have found no variations in these regions. As the promoter region of the AADAC gene contains a potential response element for aryl hydrocarbons, which could allow the induction of the gene in response to xenobiotics (Trickett et al. 2001), polymorphisms in the 5' flanking region should be investigated intensively.
References
Ariyoshi N, Sawamura Y, Kamataki T (2001) A novel single nucleotide polymorphism altering stability and activity of CYP2a6. Biochem Biophys Res Commun 281:810–814
Baek SJ, Lee K-D, Shen R-F (1996) Genomic structure and polymorphism of the human thromboxane synthase-encoding gene. Gene 173:251–256
Beresford PJ, Xia Z, Greenberg AH, Lieberman J (1999) Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. Immunity 10:585–594
Broxmeyer HE (1996) Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules? J Exp Med 183:2411–2415
Brzezinski MR, Abraham TL, Stone CL, Dean RA, Bosron WF (1994) Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem Pharmacol 48:1747–1755
Candi E, Melino G, Mei G, Tarcsa E, Chung SI, Marekov LN, Steinert PM (1995) Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein. J Biol Chem 270:26382–26390
Chevalier D, Lo-Guidice JM, Sergent E, Allorge D, Debuysere H, Ferrari N, Libersa C, Lhermitte M, Broly F (2001) Identification of genetic variants in the human thromboxane synthase gene (CYP5A1). Mutat Res 432:61–67
Curthoys NP, Hughey RP (1979) Characterization and physiological function of rat renal gamma-glutamyltranspeptidase. Enzyme 24:383–403
Daigo S, Takahashi Y, Fujieda M, Ariyoshi N, Yamazaki H, Koizumi W, Tanabe S, Saigenji K, Nagayama S, Ikeda K, Nishioka Y, Kamataki T (2002) A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards Tegafur. Pharmacogenetics 12:299–306
Dean RA, Christian CD, Sample RH, Bosron WF (1991) Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J 5:2735–2739
Ding X, Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149–173
Ekins S, Wrighton SA (1999) The role of CYP2B6 in human xenobiotic metabolism. Drug Metab Rev 31:719–754
el-Zein R, Zwischenberger JB, Wood TG, Abdel-Rahman SZ, Brekelbaum C, Au WW (1997) Combined genetic polymorphism and risk for development of lung cancer. Mutat Res 381:189–200
Fairbrother KS, Grove J, de Waziers I, Steimel DT, Day CP, Crespi CL, Daly AK (1998) Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8:543–552
FitzGerald DJ, Rocki W, Murray R, Mayo G, FitzGerald GA (1990) Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335:751–754
Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168–179
Henkart PA (1994) Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343–346
Higuchi S, Nakamura Y, Saito S (2002) Characterization of a VNTR polymorphism in the coding region of the CEL gene. J Hum Genet 47:213–215
Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS, Chhabra SK (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 89:1207–1212
Hiratsuka M, Takekuma Y, Endo N, Narahara K, Hamdy SI, Kishikawa Y, Matsuura M, Agatsuma Y, Inoue T, Mizugaki M (2002) Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population. Eur J Clin Pharmacol 58:417–421
Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SPM, Ponec M, Bon A, Lautenschlager S, Schorderet DF, Hohl D (1995) Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 267:525–528
Humerickhouse R, Lohrbach K, Li L, Bosron WF, Dolan ME (2000) Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer Res 60:1189–1192
Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, Hildesheim A, Chen CJ (1997) Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 6:901–905
Iida A, Sekine A, Saito S, Kitamura Y, Kitamoto T, Osawa S, Mishima C, Nakamura Y (2001) Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes. J Hum Genet 46:225–240
Jelinek DF, Andersson S, Slaughter CA, Russell DW (1990) Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem 265:8190–8197
Johnston SC, Larsen CN, Cook WJ, Wilkinson KD, Hill CP (1997) Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 Å resolution. EMBO J 16:3787–3796
Jones DA, Fitzpatrick FA (1991) Thromboxane A2 synthase. Modification during "suicide" inactivation. J Biol Chem 266:23510–23514
Kitagawa K, Kunugita N, Kitagawa M, Kawamoto T (2001) CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. J Biol Chem 276:17830–17835
Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin J, Suda T (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352
Laan M, Palmberg L, Larsson K, Linden A (2002) Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur Respir J 19:534–537
Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM (2001) Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 11:399–415
Larsen CN, Krantz BA, Wilkinson KD (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37:3358–3368
Lee EY-HP, Lee W-H (1986) Molecular cloning of the human esterase D gene, a genetic marker of retinoblastoma. Proc Natl Acad Sci USA 83:6337–6341
Lee W-H, Wheatley W, Benedict WF, Huang C-M, Lee EY-HP (1986) Purification, biochemical characterization, and biological function of human esterase D. Proc Natl Acad Sci USA 83:6790–6794
Lombardo D, Fauvel J, Guy O (1980) Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, glycerides and phospholipids. Biochim Biophys Acta 611:136–146
London SJ, Idle JR, Daly AK, Coetzee GA (1999) Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353:898–899
Masson D, Tschopp J (1987) A family of serine esterases in lytic granules of cytolytic T lymphocytes. Mol Pharmacol 49:679–685
Melino G, Candi E, Steinert PM (2000) Assays for transglutaminases in cell death. Science 322:433–472
Miyamoto M, Umetsu Y, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Nemoto N, Sato K, Ariyoshi N, Kamataki T (1999) CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun 261:658–660
Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108:430–438
Munger JS, Shi GP, Mark EA, Chin DT, Gerard C, Chapman HA (1991) A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem 266:18832–18838
Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y (1996a) Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 277; 1010–1015
Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y (1996b) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212–1217
Nickerson DA, Tobe VO, Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25:2745–2751
Nilsson J, Blackberg L, Carlsson P, Enerback S, Hernell O, Bjursell G (1990) cDNA cloning of human-milk bile-salt-stimulated lipase and evidence for its identity to pancreatic carboxylic ester hydrolase. Eur J Biochem 192:543–550
Nitta M, Ku S, Brown C, Okamoto AY, Shan B (1999) CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7-alpha-hydroxylase gene. Proc Natl Acad Sci USA 96:6660–6665
Oscarson M, McLellan RA, Gullstén H, Yue Q-Y, Lang MA, Bernal ML, Sinues B, Hirvonen A, Raunio H, Pelkonen O, Ingelman-Sundberg M (1999) Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett 448:105–110
Oscarson M, McLellan RA, Asp V, Ledesma M, Ruiz ML, Sinues B, Rautio A, Ingelman-Sundberg M (2002) Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity. Hum Mutat 20:275–283
Oyama T, Kawamoto T, Mizoue T, Sugio K, Kodama Y, Mitsudomi T, Yasumoto K (1997) Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res 17:583–587
Pianezza ML, Sellers EM, Tyndale RF (1998) Nicotine metabolism defect reduces smoking. Nature 393:750
Pindel EV, Kedishvili NY, Abraham TL, Brzezinski MR, Zhang J, Dean RA, Bosron WF (1997) Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J Biol Chem 272:14769–14775
Pitarque M, Richter O von, Oke B, Berkkan H, Oscarson M, Ingelman-Sundberg M (2001) Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity. Biochem Biophys Res Commun 284:455–460
Probst MR, Jeno P, Meyer UA (1991) Purification and characterization of a human liver arylacetamide deacetylase. Biochem Biophys Res Commun 177:453–459
Rivera SP, Saarikoski ST, Hankinson O (2002) Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 61:255–259
Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a Herpes virus saimiri gene. J Immunol 150:5445–5456
Russell LJ, DiGiovanna JJ, Rogers GR, Steinert PM, Hashem N, Compton JG, Bale SJ (1995) Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nature Genet 9:279–283
Rylander T, Neve EP, Ingelman-Sundberg M, Oscarson M (2001) Identification and tissue distribution of the novel human cytochrome P4502S1 (CYP2S1). Biochem Biophys Res Commun 281:529–535
Saito S, Iida A, Sekine A, Eguchi C, Miura Y, Nakamura Y (2001) Seventy genetic variations in human microsomal and soluble epoxide hydrolase genes (EPHX1 and EPHX2) in the Japanese population. J Hum Genet (2001) 46:325–329
Satoh T, Hosokawa M (1998) The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol 38:257–288
Schulman JD, Goodman SI, Mace JW, Patrick AD, Tietze F, Butler EJ (1975) Glutathionuria: inborn error of metabolism due to tissue deficiency of gamma-glutamyl transpeptidase. Biochem Biophys Res Commun 65:68–74
Sekine A, Saito S, Iida A, Mitsunobu Y, Higuchi S, Harigae S, Nakamura Y (2001) Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1, and L1CAM in the Japanese population. J Hum Genet 46:314–319
Setchell KDR, Schwarz M, O'Connell NC, Lund EG, Davis DL, Lathe R, Thompson HR, Tyson RW, Sokol RJ, Russell DW (1998) Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7-alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 102:1690–1703
Shen RF, Tai HH (1986) Immunoaffinity purification and characterization of thromboxane synthase from porcine lung. J Biol Chem 261:11592–11599
Shi L, Kraut RP, Aebersold R, Greenberg AH (1992a) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175:553–566
Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH (1992b) Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 176:1521–1529
Shresta S, Graubert TA, Thomas DA, Raptis SZ, Ley TJ (1999) Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity 10:595–605
Su T, Bao Z, Zhang Q-Y, Smith TJ, Hong J-Y, Ding X (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074–5079
Sun F, Tsuritani I, Honda R, Ma ZY, Yamada Y (1999) Association of genetic polymorphisms of alcohol-metabolizing enzymes with excessive alcohol consumption in Japanese men. Hum Genet 105:295–300
Tanaka F, Shiratori Y, Yokosuka O, Imazeki F, Tsukada Y, Omata M (1997) Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcohol Clin Exp Res 21:596–601
Trickett JI, Patel DD, Knight BL, Saggerson ED, Gibbons GF, Pease RJ (2001) Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulation. J Biol Chem 276:39522–39532
Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC (1998) Linkage between cholesterol 7-alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. J Clin Invest 101:1283–1291
Wilkinson KD, Lee K, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246:670–673
Wright EC, Stern J, Ersser R, Patrick AD (1980) Glutathionuria: gamma-glutamyl transpeptidase deficiency. J Inherit Metab Dis 2:3-7
Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR (1997) Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18:967–973
Wu Z, Martin KO, Javitt NB, Chiang JYL (1999) Structure and functions of human oxysterol 7-alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 40:2195–2203
Xu C, Rao YS, Xu B, Hoffmann E, Jones J, Sellers EM, Tyndale RF (2002) An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochem Biophys Res Commun 290:318–324
Zhang X, Su T, Zhang QY, Gu J, Caggana M, Li H, Ding X (2002) Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J Pharmacol Exp Ther 302:416–423
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saito, S., Iida, A., Sekine, A. et al. Catalog of 680 variations among eight cytochrome P450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population. J Hum Genet 48, 249–270 (2003). https://doi.org/10.1007/s10038-003-0021-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10038-003-0021-7
Keywords
This article is cited by
-
Carboxylesterases in lipid metabolism: from mouse to human
Protein & Cell (2018)
-
Pharmacogenomics and therapeutic prospects in dementia
European Archives of Psychiatry and Clinical Neuroscience (2008)
-
Pharmacogenetic Basis for Therapeutic Optimization in Alzheimer’s Disease
Molecular Diagnosis & Therapy (2007)
-
Identification of 156 novel SNPs in 29 genes encoding G-protein coupled receptors
Journal of Human Genetics (2005)
-
Inference from the relationships between linkage disequilibrium and allele frequency distributions of 240 candidate SNPs in 109 drug-related genes in four Asian populations
Journal of Human Genetics (2004)